Financials
- Market Capitalization 2.29 B
- Employee 890
- Founded 1996
- CEO Matthew M. Mannelly
- Website www.prestigebrands.com
- Headquarter New York, United States
- FIGI BBG000QM0RZ4
- Industry Fabricants de Médicaments — Spécialités et Génériques
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
15.16
ratio cours/chiffre d'affaires
2.79
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1779 | SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 47.73 USD | +2.29% | -5.86% | +10.05% | -11.61% | 2.77 B USD | ||
| 1842 | RGC Regencell Bioscience Holdings Limited - Ordinary Shares | 5.13 USD | -9.20% | -19.97% | -69.46% | -69.17% | 2.54 B USD | ||
| 1989 | HCM HUTCHMED (China) Limited - American Depositary Shares | 11.59 USD | +3.02% | +3.67% | +11.55% | -32.81% | 2.02 B USD | ||
| 2057 | ANIP ANI Pharmaceuticals, Inc. - Common Stock | 80.82 USD | +0.34% | -4.00% | -2.63% | -14.59% | 1.84 B USD |